LAWRENCE, Mass., Oct. 18, 2018 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, announced new findings demonstrating ...

NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, ...

NxStage Medical (NASDAQ: NXTM) has revolutionized the way that dialysis patients receive treatment, with its home-dialysis devices offering a much more convenient alternative to visiting outpatient ...

NxStage Medical Inc. and Spindial S.p.A., a distributor of renal care products in Italy, announced a partnership with the Niguarda-Ca’ Granda hospital in Milan assist hemodialysis patients. The ...

NxStage (NXTM) - Get Free Report surged 35% after signing a home dialysis partnership with DaVita (DVA) - Get Free Report. DaVita said it bought $20 million in NxStage stock, giving it a 7% stake.

The home-dialysis market is a growing one because of the rise in incidence of diabetes and other diseases that can have an impact on kidney function. NxStage Medical (NASDAQ: NXTM) has done its best ...

Feb 8 (Reuters) - Shares of medical equipment maker NxStage Medical Inc. topped the Nasdaq gainers list on Thursday, surging almost 50 percent, a day after news that DaVita Inc. has acquired about 7 ...